CoreWeave's growing revenue and large backlog have not translated into positive fundamentals. Its trailing free cash flow has fallen to -$13.65 billion, net income to -$1.93 billion and EPS to -$3.66; the stock may still work out, but the uncertainty warrants caution. x.com 

Core Scientific's selloff over doubts about CoreWeave misses that, if CoreWeave cannot meet its obligations, Core Scientific can re-lease that capacity at 40-60% higher rates. Most of its capacity is tied to CoreWeave, which is why the stock is being hit as CoreWeave's viability is questioned. x.com 

Core Scientific's failure to secure a data center deal in an environment this strong is a bad sign, coming after the CoreWeave delays. x.com 

CoreWeave looks like a poor long because its debt now exceeds its market capitalization. x.com 

Improving per-MW pricing, falling cost of capital and stronger-than-expected demand from Anthropic and OpenAI make CoreWeave one of three absolute favorite stocks on a massive sale. Its short-term deals can command 3-4 times the pricing of long-term contracts. x.com 

Core Scientific looks attractive as a catch-up trade. x.com 

CoreWeave looks positioned to be one of the biggest beneficiaries of years of demand for GPU computing at scale. It should be one of the most important players in the AI infrastructure buildout, with Jensen Huang and Nvidia deeply tied to it. At $50 a share, its debt load is not a concern; the stock could look like one of the best buying opportunities by decade-end. x.com  x.com 

CoreWeave's stock may already reflect much of its real financing risk amid extreme pessimism. Its unsecured bonds yield distressed rates and CDS spreads have surged, while Q2 net interest expense was $640M and 2026 capex guidance is $35–39B. Q2 revenue was $2.58B with about $104B of backlog, but whether that demand yields shareholder value after financing, depreciation and reinvestment remains uncertain; attractive financing is central to the case. x.com 

CoreWeave's 3.2x 2027 revenue multiple makes it one of the most attractive stocks in the market. x.com 

CoreWeave's pricing power is overlooked amid financing fears, making it potentially the most misunderstood AI stock right now. It had over $104B in Q2 backlog and signed $25B in net new commitments over six weeks. Short-term contracts approach $40M per MW annually versus about $7M on active capacity, but that rate cannot be applied fleetwide. A $4.2B convertible carried a 2.875% coupon despite near-15% unsecured bond yields; $35B debt, dilution and capacity-conversion risks remain. x.com